Harvard Heart Letter

Heart Beat: Too soon to sell a gene test for warfarin?

Determining the correct dosage of warfarin for a heart patient can take several weeks. A company is selling a test that it claims will shorten the process, but there is no evidence yet to support the claim.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In